These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3420282)

  • 1. Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy.
    Segel MC; Paulus DD; Hortobagyi GN
    Radiology; 1988 Oct; 169(1):49-54. PubMed ID: 3420282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of mammography in breast preservation in locally advanced breast cancer.
    Pierce L; Adler D; Helvie M; Lichter A; Merajver S
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):571-7. PubMed ID: 8621280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
    Chagpar AB; Middleton LP; Sahin AA; Dempsey P; Buzdar AU; Mirza AN; Ames FC; Babiera GV; Feig BW; Hunt KK; Kuerer HM; Meric-Bernstam F; Ross MI; Singletary SE
    Ann Surg; 2006 Feb; 243(2):257-64. PubMed ID: 16432360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy.
    Helvie MA; Joynt LK; Cody RL; Pierce LJ; Adler DD; Merajver SD
    Radiology; 1996 Feb; 198(2):327-32. PubMed ID: 8596826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast conservation after induction chemotherapy for locally advanced breast cancer.
    Kling KM; Ostrzega N; Schmit P
    Am Surg; 1997 Oct; 63(10):861-4. PubMed ID: 9322658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.
    Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M
    Anticancer Res; 2000; 20(6B):4373-7. PubMed ID: 11205274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.
    Sataloff DM; Mason BA; Prestipino AJ; Seinige UL; Lieber CP; Baloch Z
    J Am Coll Surg; 1995 Mar; 180(3):297-306. PubMed ID: 7874340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally advanced breast carcinoma: evaluation of mammography in the prediction of residual disease after induction chemotherapy.
    Huber S; Wagner M; Zuna I; Medl M; Czembirek H; Delorme S
    Anticancer Res; 2000; 20(1B):553-8. PubMed ID: 10769724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer.
    Moliterni A; Tarenzi E; Capri G; Terenziani M; Bertuzzi A; Grasselli G; Agresti R; Piotti P; Greco M; Salvadori B; Pilotti S; Lombardi F; Valagussa P; Bonadonna G; Gianni L
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-10-S17-14. PubMed ID: 9374085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response.
    Rajan R; Poniecka A; Smith TL; Yang Y; Frye D; Pusztai L; Fiterman DJ; Gal-Gombos E; Whitman G; Rouzier R; Green M; Kuerer H; Buzdar AU; Hortobagyi GN; Symmans WF
    Cancer; 2004 Apr; 100(7):1365-73. PubMed ID: 15042669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems in evaluating response of primary breast cancer to systemic therapy.
    Cocconi G; Di Blasio B; Alberti G; Bisagni G; Botti E; Peracchia G
    Breast Cancer Res Treat; 1984; 4(4):309-13. PubMed ID: 6549147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
    Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
    Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly paclitaxel improved pathologic response of primary chemotherapy compared with standard 3 weeks schedule in primary breast cancer.
    Qi M; Li JF; Xie YT; Lu AP; Lin BY; Ouyang T
    Breast Cancer Res Treat; 2010 Aug; 123(1):197-202. PubMed ID: 20582466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma.
    Zhang F; Yang Y; Smith T; Kau SW; McConathy JM; Esteva FJ; Kuerer HM; Symmans WF; Buzdar AU; Hortobagyi GN; Pusztai L
    Cancer; 2003 Apr; 97(7):1758-65. PubMed ID: 12655533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy for Chinese women with locally advanced breast cancer.
    Chow LW; Day W; Ng KC
    Am Surg; 2001 May; 67(5):412-6. PubMed ID: 11379638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of paclitaxel and carboplatin versus combination chemotherapy with fluorouracil, doxorubicin and cyclophosphamide as a neoadjuvant therapy in patients with inoperable breast cancer.
    Akhtar MS; Kousar F; Masood M; Fatimi S; Kokab
    J Coll Physicians Surg Pak; 2010 Nov; 20(11):748-52. PubMed ID: 21078249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The degree of tumor vascularization as a prognostic factor of the efficacy of neoadjuvant polychemotherapy in breast cancer].
    Voznyĭ EK; Biakhov MIu; Gorb AI; Krivenko EV; Chkhikvadze VD; Alipchenko LA; Agrinskaia IA
    Vopr Onkol; 1992; 38(7):818-23. PubMed ID: 1338674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of neoadjuvant chemotherapy +/- letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial.
    Mohammadianpanah M; Ashouri Y; Hoseini S; Amadloo N; Talei A; Tahmasebi S; Nasrolahi H; Mosalaei A; Omidvari S; Ansari M; Mosleh-Shirazi MA
    Breast Cancer Res Treat; 2012 Apr; 132(3):853-61. PubMed ID: 22002564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease.
    Fiorentino C; Berruti A; Bottini A; Bodini M; Brizzi MP; Brunelli A; Marini U; Allevi G; Aguggini S; Tira A; Alquati P; Olivetti L; Dogliotti L
    Breast Cancer Res Treat; 2001 Sep; 69(2):143-51. PubMed ID: 11759820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.